Physician profile
Ashley Sharp
NPI 1285491621
$1,205.20
in general payments reported to CMS, 2019-2025
10 companies · $910 in 2025
The $910 reported for 2025 was more than what 79% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $295 · 2025: $910.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,205.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $620.56 | 2024-2025 | Fasenra, Tezspire, Breztri |
| Regeneron Healthcare Solutions, INC. | $172.47 | 2024-2025 | Dupixent |
| Bayer Healthcare Pharmaceuticals INC. | $136.31 | 2025 | |
| Philips North America LLC | $87.21 | 2024-2025 | Vest Therapy Und, Incourage Airway Clearance Therapy, (Ak6) Vest Therapy |
| Verona Pharma, INC. | $62.97 | 2025 | Ohtuvayre |
| Viatris Specialty LLC | $53.41 | 2025 | Yupelri |
| Novartis Pharmaceuticals Corporation | $20.56 | 2024 | |
| Pfizer INC. | $19.23 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.99 | 2024 | Glassia |
| Breas Medical, INC. | $15.49 | 2025 | Vivo 45 Ls |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Sharp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.